Ad is loading...
KALA
Price
$6.55
Change
+$0.12 (+1.87%)
Updated
Nov 21 closing price
MDWD
Price
$16.76
Change
-$0.02 (-0.12%)
Updated
Nov 21 closing price
4 days until earnings call
Ad is loading...

KALA vs MDWD

Header iconKALA vs MDWD Comparison
Open Charts KALA vs MDWDBanner chart's image
Kala BIO
Price$6.55
Change+$0.12 (+1.87%)
Volume$23.74K
CapitalizationN/A
MediWound
Price$16.76
Change-$0.02 (-0.12%)
Volume$44.68K
CapitalizationN/A
KALA vs MDWD Comparison Chart
Loading...
KALA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KALA vs. MDWD commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Sell and MDWD is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (KALA: $6.55 vs. MDWD: $16.76)
Brand notoriety: KALA and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 102% vs. MDWD: 109%
Market capitalization -- KALA: $30.2M vs. MDWD: $180.84M
KALA [@Biotechnology] is valued at $30.2M. MDWD’s [@Biotechnology] market capitalization is $180.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, MDWD is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 5 TA indicator(s) are bullish while MDWD’s TA Score has 4 bullish TA indicator(s).

  • KALA’s TA Score: 5 bullish, 5 bearish.
  • MDWD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KALA is a better buy in the short-term than MDWD.

Price Growth

KALA (@Biotechnology) experienced а -3.11% price change this week, while MDWD (@Biotechnology) price change was +2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

KALA is expected to report earnings on May 09, 2023.

MDWD is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDWD($181M) has a higher market cap than KALA($30.2M). MDWD YTD gains are higher at: 64.798 vs. KALA (-6.429). MDWD has higher annual earnings (EBITDA): -4.54M vs. KALA (-32.84M). KALA has more cash in the bank: 49.2M vs. MDWD (29.2M). MDWD has less debt than KALA: MDWD (6.36M) vs KALA (37M). MDWD has higher revenues than KALA: MDWD (20.1M) vs KALA (0).
KALAMDWDKALA / MDWD
Capitalization30.2M181M17%
EBITDA-32.84M-4.54M723%
Gain YTD-6.42964.798-10%
P/E RatioN/AN/A-
Revenue020.1M-
Total Cash49.2M29.2M168%
Total Debt37M6.36M582%
FUNDAMENTALS RATINGS
KALA vs MDWD: Fundamental Ratings
KALA
MDWD
OUTLOOK RATING
1..100
7461
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4446
P/E GROWTH RATING
1..100
974
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KALA's Valuation (63) in the Pharmaceuticals Major industry is in the same range as MDWD (74) in the Pharmaceuticals Other industry. This means that KALA’s stock grew similarly to MDWD’s over the last 12 months.

KALA's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as MDWD (100) in the Pharmaceuticals Other industry. This means that KALA’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that MDWD’s stock grew similarly to KALA’s over the last 12 months.

KALA's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as MDWD (46) in the Pharmaceuticals Other industry. This means that KALA’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (4) in the Pharmaceuticals Other industry is significantly better than the same rating for KALA (97) in the Pharmaceuticals Major industry. This means that MDWD’s stock grew significantly faster than KALA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KALAMDWD
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 26 days ago
77%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
KALA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEG92.351.86
+2.06%
Public Service Enterprise Group
PALT1.780.03
+1.78%
Paltalk
MMSI105.030.95
+0.91%
Merit Medical Systems
DGII31.48-0.07
-0.22%
Digi International
ATAI1.52-0.07
-4.40%
ATAI Life Sciences NV

KALA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALA has been loosely correlated with ATHE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KALA jumps, then ATHE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
+1.87%
ATHE - KALA
36%
Loosely correlated
+1.90%
PALI - KALA
31%
Poorly correlated
N/A
ARDX - KALA
28%
Poorly correlated
+4.07%
ENTX - KALA
27%
Poorly correlated
+4.52%
UNCY - KALA
27%
Poorly correlated
+3.61%
More

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
-0.12%
PHIO - MDWD
35%
Loosely correlated
+6.30%
AKRO - MDWD
33%
Poorly correlated
+1.84%
KALA - MDWD
26%
Poorly correlated
+1.87%
VCEL - MDWD
26%
Poorly correlated
-0.96%
SYBX - MDWD
26%
Poorly correlated
-2.75%
More